发光:在被忽视的社区推进健康平等
Elaine T Kiriakopoulos1, Rebecca García Sosa2, Leah Blank3
1Department of Neurology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.
Epilepsy currents
|November 18, 2024
概括
在中实现健康公平需要解决系统性障碍和所有个人健康的社会决定因素. 本综述强调了少数群体病护理方面的差异,并提出了改善获得和结果的解决方案.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
背景情况:
- 在中获得公平的健康需要解决系统性障碍和健康的社会决定因素.
- 治疗中的差异不成比例地影响了少数群体.
- 健康的社会决定因素显著影响的流行率,治疗机会和结果.
研究的目的:
- 审查有关影响少数群体的健康差异的文献.
- 为低社会经济地位,非英语偏好,性和性别少数群体和农村社区分享早期解决方案.
- 催化利益相关者的投资,以解决在提供者和卫生系统层面的健康差异.
主要方法:
- 对影响的少数群体差异的文献综述.
- 识别早期解决方案和复制最佳实践.
- 对缺乏服务的社区健康负担的社会决定因素的分析.
主要成果:
- 在患有的少数群体中存在显著的健康差异.
- 为多样化,服务不足的社区提供可复制解决方案的例子.
- 需要创新性研究来界定不同人群中患病率,获取和结果.
结论:
- 解决系统性障碍和健康的社会决定因素对于健康公平至关重要.
- 基于证据的方法对于减少差异和支持患者至关重要.
- 需要进一步的研究和利益相关者投资,才能在治疗中实现健康公平.
相关概念视频
Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
Seizures: Classification
303
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
303
Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284
Antiepileptic Drugs: GABAergic Pathway Potentiators
334
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
334
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


